NCT04720963View on ClinicalTrials.gov

Intranasal Remimazolam for Premedication in Pediatric Patient

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 7, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Sedative; Anxiety Disorder
Interventions
DRUG

Remimazolam

intranasal remimazolam

OTHER

Distilled water for injection

intranasal distilled water for injection

DRUG

Dexmedetomidine

Intranasal dexmedetomidine

Trial Locations (1)

Unknown

The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT04720963 - Intranasal Remimazolam for Premedication in Pediatric Patient | Biotech Hunter | Biotech Hunter